Kimberly Greco

Kimberly Greco is Director of Global Regulatory and Research and Development Policy at Amgen and leads Amgen’s Biosimilar Policy Team. Ms. Greco has been engaged in legislative and regulatory policy related to biosimilars since joining Amgen in 2004. Prior to Amgen, Ms. Greco was an attorney with the law firm of Hogan and Hartson in the Health and Drug practice groups. Ms. Greco’s health policy experience includes serving as a health staffer in the U.S. House of Representatives. She also worked in the U.S. Department of Justice and the Ohio state legislature. Kim is a graduate of the Boston College Law School and Miami University in Ohio.